Butobarbital
From Wikipedia, the free encyclopedia
 |
|
|
Butobarbital
|
|
| Systematic (IUPAC) name | |
| 5-butyl-5-ethyl-1,3-diazinane-2,4,6-trione | |
| Identifiers | |
| CAS number | 77-28-1 |
| ATC code | N05CA03 |
| PubChem | 6473 |
| DrugBank | APRD00752 |
| Chemical data | |
| Formula | C10H16N2O3 |
| Mol. weight | 212.246 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
? |
| Routes | Oral |
Butobarbital (also known as Soneryl) is a drug which is a barbiturate derivative. It is prescribed for severe insomnia.
| Barbiturates edit | ||
|---|---|---|
|
Allobarbital, Amobarbital, Aprobarbital, Barbexaclone, Barbital, Butabarbital, Butalbital, Butobarbital, Cyclobarbital, Ethallobarbital, Heptabarbital, Hexobarbital, Mephobarbital, Metharbital, Methohexital, Methylphenobarbital, Pentobarbital, Phenobarbital, Primidone, Proxibarbal, Reposal, Secobarbital, Talbutal, Thiobarbital, Thiopental, Vinbarbital, Vinylbital |
||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
